N-1-Alkyl-2-oxo-2-aryl amides as novel antagonists of the TRPA1 receptor

被引：13

作者：

Vallin, Karl S. A. ^{[1
]}

Sterky, Karin J. ^{[1
]}

Nyman, Eva ^{[2
]}

Bernstrom, Jenny ^{[2
,3
]}

From, Rebecka ^{[1
]}

Linde, Christian ^{[1
]}

Minidis, Alexander B. E. ^{[1
]}

Nolting, Andreas ^{[2
,3
]}

Narhi, Katja ^{[1
]}

Santangelo, Ellen M. ^{[1
]}

Sehgelmeble, Fernando W. ^{[1
]}

Sohn, Daniel ^{[1
]}

Strindlund, Jennie ^{[4
]}

Weigelt, Dirk ^{[1
]}

机构：

[1] AstraZeneca R&D, Innovat Med, Med Chem, CNSP iMed, SE-15185 Sodertalje, Sweden

[2] AstraZeneca R&D, Innovat Med, Discovery Sci, SE-15185 Sodertalje, Sweden

[3] AstraZeneca R&D, Innovat Med, Discovery Sci, SE-43183 Molndal, Sweden

[4] AstraZeneca R&D, Innovat Med, Neurosci, CNSP iMed, SE-15185 Sodertalje, Sweden

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2012年 / 22卷 / 17期

关键词：

Ion channel; TRPA1; Antagonist; ACTIVATE TRPA1; CHANNEL; DISCOVERY; A1;

D O I：

10.1016/j.bmcl.2012.07.032

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of potent antagonists of the ion channel transient receptor potential A1 (TRPA1) was developed by modifying lead structure 16 that was discovered by high-throughput screening. Based on lead compound 16, a SAR was established, showing a narrow region at the nitro-aromatic R-1 moiety and at the warhead, while the R-2 side had a much wider scope including ureas and carbamates. Compound 16 inhibits Ca2+-activated TRPA1 currents reversibly in whole cell patch clamp experiments, indicating that under in vivo conditions, it does not react covalently, despite its potentially electrophilic ketone. (c) 2012 Elsevier Ltd. All rights reserved.

引用

页码：5485 / 5492

页数：8

共 50 条

[1] α-Aryl pyrrolidine sulfonamides as TRPA1 antagonists
Verma, Vishal A.
Shore, Daniel G. M.
Chen, Huifen
Chen, Jun
Do, Steven
Hackos, David H.
Kolesnikov, Aleks
Lyssikatos, Joseph P.
Tay, Suzanne
Wang, Lan
Estrada, Anthony A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (02) : 495 - 498
[2] Transient receptor potential ankyrin 1 (TRPA1) antagonists
Preti, Delia
Saponaro, Giulia
Szallasi, Arpad
PHARMACEUTICAL PATENT ANALYST, 2015, 4 (02) : 75 - 94
[3] Development of novel azabenzofuran TRPA1 antagonists as in vivo tools
Copeland, Katrina W.
Boezio, Alessandro A.
Cheung, Eugene
Lee, Josie
Olivieri, Philip
Schenkel, Laurie B.
Wan, Qian
Wang, Weiya
Wells, Mary C.
Youngblood, Beth
Gavva, Narender R.
Lehto, Sonya G.
Geuns-Meyer, Stephanie
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (15) : 3464 - 3468
[4] Activation of TRPA1 channels by novel N-nitrosamines
Kozai, Daisuke
Maximilian, Ebert
Karaki, Fumika
Otani, Yuko
Kabasawa, Yoji
Takahashi, Nobuaki
Numata, Tomohiro
Kiyonaka, Shigeki
Ohwada, Tomohiko
Mori, Yasuo
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 148P - 148P
[5] Novel TRPA1 Antagonists are Multimodal Blockers of Human TRPA1 Channels: Drug Candidates for Treatment of Familial Episodic Pain Syndrome (FEPS)
Herz, Jeffrey
Buated, Wannipat
Thomsen, William
Mori, Yasuo
FASEB JOURNAL, 2020, 34
[6] Discovery of Dual TRPA1 and TRPV1 Antagonists as Novel Therapeutic Agents for Pain
Do, Nayeon
Zuo, Dongxu
Kim, Miri
Kim, Minseok
Ha, Hee-Jin
Blumberg, Peter M.
Ann, Jihyae
Hwang, Sun Wook
Lee, Jeewoo
PHARMACEUTICALS, 2024, 17 (09)
[7] TRANSIENT RECEPTOR POTENTIAL ANKYRIN 1 (TRPA1) AS A FACTOR AND DRUG TARGET IN OSTEOARTHRITIS: TRPA1 MEDIATES FIBROBLAST GROWTH FACTOR 2 EXPRESSION IN CHONDROCYTES
Nummenmaa, E.
Hamalainen, M.
Pemmari, A.
Moilanen, L. J.
Nieminen, R.
Moilanen, T.
Vuolteenaho, K.
Moilanen, E.
OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S377 - S377
[8] Transient receptor potential ankyrin 1 (TRPA1) antagonists: a patent review (2015-2019)
Chen, Huifen
Terrett, Jack A.
EXPERT OPINION ON THERAPEUTIC PATENTS, 2020, 30 (09) : 643 - 657
[9] Discovery, Optimization, and Biological Evaluation of 5-(2-(Trifluoromethyl)phenyl)indazoles as a Novel Class of Transient Receptor Potential A1 (TRPA1) Antagonists
Rooney, Lisa
Vidal, Agnes
D'Souza, Anne-Marie
Devereux, Nick
Masick, Brian
Boissel, Valerie
West, Ryan
Head, Victoria
Stringer, Rowan
Lao, Jianmin
Petrus, Matt J.
Patapoutian, Ardem
Nash, Mark
Stoakley, Natalie
Panesar, Moh
Verkuyl, J. Martin
Schumacher, Andrew M.
Petrassi, H. Michael
Tully, David C.
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (12) : 5129 - 5140
[10] Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor
DeFalco, Jeff
Steiger, Daniel
Gustafson, Amy
Emerling, Daniel E.
Kelly, Michael G.
Duncton, Matthew A. J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) : 276 - 279

← 1 2 3 4 5 →